ACI-19626
TDP-43-IN-2 (compound 17) is a TDP-43 inhibitor, and can be used for study of neurodegenerative disease[1].
Product Specifications
CAS Number
[3033951-93-5]
Product Name Alternative
TDP-43-IN-2
UNSPSC
12352005
Target
Amyloid-β
Type
Reference compound
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/tdp-43-in-2.html
Purity
98.52
Solubility
DMSO : 5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C1C2=C(CCN1C3=CC=CN=C3)N=C(C4=C(F)N=C(N5CCC(CC5)CO)C=C4)S2
Molecular Formula
C22H22FN5O2S
Molecular Weight
439.51
References & Citations
[1]Nicolas Dreyfus, et al. Novel compounds for the diagnosis of tdp-43 proteinopathies. WO2024068948A1. 2024-04-04.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![[Leu31Pro34]-Neuropeptide Y (human rat)](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
MBS6308017-01 0.1 mL
Hoxc4, ID (Hoxc4, Hox-3.5, Hoxc-4, Homeobox protein Hox-C4, Homeobox protein Hox-3.5) (MaxLight 405)
Ask
View Details MBS6308017-02 5x 0.1 mL
Hoxc4, ID (Hoxc4, Hox-3.5, Hoxc-4, Homeobox protein Hox-C4, Homeobox protein Hox-3.5) (MaxLight 405)
Ask
View Details